Major Scientific AIDS Conference, Paris July 13-16; Reports Online
Scientists will present results of basic medical research and of HIV drug clinical trials at the International AIDS Society conference in Paris in mid July.
New Protease Inhibitor Atazanavir (Reyataz) Approved
A new protease inhibitor has much less effect than others in raising blood levels of cholesterol and triglycerides, probably reducing some health risks -- but early data suggests that this benefit may not translate into reduced lipodystrophy. There are other side effects, and doctors and patients will need to be especially careful about drug interactions.
Federal AIDS Policy Emergencies
Federal policy problems and changes urgently need attention. Here we note some of what is happening in Social Security disability, ADAP, Medicaid, Medicare, prevention, and basic biomedical research.
AIDS, Computers, and Organizing: Part I, Toward a Revolution in Fundraising? A Report From the Planetwork Conference
This month I attended Planetwork, a three-day meeting in San Francisco on new online tools for social organizing, to improve civil society and allow people around the world to work together for common projects and goals. Over 100 presenters told of many important experiments and a few spectacular successes -- mostly unknown in the AIDS world today. These advances will change how we live and work, and AIDS activists and organizations will benefit by knowing about them and taking a lead in exploring how to use this work to help solve problems we face. This article is the first of three reports on these developments that AIDS Treatment News will publish over the next few months.
ISSN # 1052-4207
Copyright 2003 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.